Xiangmin Tong

10PUBLICATIONS
22CO-AUTHORS
Gene and molecular therapyCancer therapy (excl. chemotherapy and radiation therapy)Predictive and prognostic markersHaematological tumoursMolecular targets
Featured researcher

Get your video featured.

JoVEPublish with JoVE
Journal

Publications (10)

|Aug 12, 2026
TIM3-targeted delivery of venetoclax overcomes drug resistance and reinvigorates NK cell activity in acute myeloid leukemia.

|Jul 19, 2025
Status and Prospects of Glioblastoma Multiforme Treatments.

Xue Yang, Shibing Wang, Vedrana Montana

|Jul 03, 2025
Author Correction: Safety and feasibility of 4-1BB co-stimulated CD19-specific CAR-NK cell therapy in refractory/relapsed large B cell lymphoma: a phase 1 trial.

Wen Lei, Hui Liu, Wenhai Deng

|May 22, 2025
Tumor Pro-Senescence Strategy to Enhance Mild Photothermal Therapy of Diffuse Large B-Cell Lymphoma.

Yehui Kang, Liya Yu, Yang Chen

|Apr 18, 2025
Safety and feasibility of 4-1BB co-stimulated CD19-specific CAR-NK cell therapy in refractory/relapsed large B cell lymphoma: a phase 1 trial.

Wen Lei, Hui Liu, Wenhai Deng

|May 05, 2022
Functional deficiency of succinate dehydrogenase promotes tumorigenesis and development of clear cell renal cell carcinoma through weakening of ferroptosis.

Jing Yang, Yi Zhou, Yanchun Li

Pageof 2

Frequent Collaborators

4 joint publications

Ying Wang

3 joint publications

Jing Du

2 joint publications

Wenbin Qian

2 joint publications

Hui Liu